Work

Association of California’s Prescription Drug Coupon Ban With Generic Drug Use

Year: 2021

Type: article

Abstract: This pharmacoepidemiology study uses insurance claims data to compare generic substitutions for drugs with vs without manufacturer copayment coupons in California vs surrounding states in the year before and after a January 2018 California ban on coupons intended to incentivize use of more expensive brand-name medication.

Source: JAMA

DOI: 10.1001/jama.2021.6568

Authors: Benjamin N. Rome, Joshua J. Gagne, Aaron S. Kesselheim

Institution: Brigham and Women's Hospital

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bill and Melinda Gates Foundation, American Beverage Association, Arnold Ventures, National Institute on Aging